Zydus Naftifine HCL 2% Cream Gets CDSCO Panel nod to treat superficial fungal infection of skin Dr. Divya Colin1 Nov 2022 6:00 PM ISTNew Delhi: Pharmaceutical major, Zydus has got green signal from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Glenmark gets CDSCO Panel nod to manufacture,market Lobeglitazone, Metformin antidiabetic FDC Susmita Roy31 Oct 2022 6:00 PM ISTNew Delhi: Highlighting the clinical trial results that demonstrate the efficacy and safety of combination treatment of Lobeglitazone and Metformin in...
NPPA Panel Fixes Retail Price Of Sachet containing Pantoprazole 40mg marketed by Alkem Dr. Divya Colin30 Oct 2022 1:00 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of a sachet containing Pantoprazole Sodium equivalent...
Amoxicillin linked to Fixed Drug Eruption: Indian Pharmacopoeia Commission Drug Safety Alert Susmita Roy29 Oct 2022 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of October has revealed that...
NPPA Panel Suggests Retail Price of Atorvastatin,Bempedoic Acid FDC Marketed By Zydus Healthcare Dr. Divya Colin28 Oct 2022 6:00 PM IST New Delhi: The National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of each film coated tablet containing...
No need of prescription from Doctors for Refresh Tears: DTAB Dr. Divya Colin27 Oct 2022 6:00 PM ISTNew Delhi: Granting drug maker Allergan India request to change the category of "Refresh Tears" from prescription drug to over the counter drug, the...
Pharmacy Council of India mandates urgent implementation of Pharmacy Practice Regulations for pharmacists Dr. Divya Colin26 Oct 2022 12:30 PM ISTNew Delhi: Through a recent notification, the Pharmacy Council of India (PCI) has directed all the State and Union Territory (UT) governments and...
Denying Abbott proposal DTAB rules Zolpidem continues to be Schedule H1 drug Dr. Divya Colin25 Oct 2022 11:30 AM ISTNew Delhi: Denying the pharma major Abbott India proposal to change schedule of Zolpidem Tartrate from Schedule H1 to Schedule H of the Drugs Rules,...
Pharma D automatically eligible for posts meant for Bpharma, D Pharma: PCI issues clarification Farhat Nasim24 Oct 2022 10:45 AM ISTNew Delhi: Through a recent notification, the Union Health Ministry has clarified that a person holding the Doctor of Pharmacy (Pharm. D)...
AstraZeneca Gets CDSCO panel nod to Import, Market Anti-Diabetic Dapagliflozin for Additional Indication Dr. Divya Colin23 Oct 2022 11:30 AM ISTNew Delhi: Pharmaceutical major AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
Are pharma firms indulging in illegal activities to spread viral diseases? TN HC orders probe Farhat Nasim22 Oct 2022 6:00 PM ISTChennai: The Madras High Court has directed the Tamil Nadu government to conduct an inquiry to ascertain whether any pharmaceutical company has a role...
SII gets CDSCO panel nod to study Pneumococcal Polysaccharide Conjugate Vaccine,Adsorbed,10-Valent Dr. Divya Colin21 Oct 2022 6:00 PM ISTNew Delhi: Serum Institute of India has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
